Search

everythinglearnresearchcommunity

for

Search:↓

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

Aromatase inhibitors cause male pattern hair loss in women.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Some breast cancer chemotherapy can cause permanent hair loss.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Spironolactone and minoxidil together effectively treat female pattern hair loss.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Hair loss gene linked to prostate issues.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

A man with total hair loss also developed a rare nail condition, likely due to autoimmune issues.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.